Holen Sie sich die Stockscreener-App
0.9631
0.95%
0.0091
Schlusskurs vom Vortag:
$0.954
Offen:
$0.95
24-Stunden-Volumen:
173.70K
Relative Volume:
0.40
Marktkapitalisierung:
$28.44M
Einnahmen:
$69.23M
Nettoeinkommen (Verlust:
$-33.10M
KGV:
-0.8523
EPS:
-1.13
Netto-Cashflow:
$-39.26M
1W Leistung:
+20.01%
1M Leistung:
-2.72%
6M Leistung:
-55.82%
1J Leistung:
-32.18%
1-Tages-Spanne:
$0.92
$0.9808
1-Wochen-Bereich:
$0.76
$1.04
52-Wochen-Spanne:
$0.52
$5.0699
Neuronetics Inc Stock (STIM) Company Profile
Firmenname
Neuronetics Inc
Sektor
Branche
Telefon
877-600-7555
Adresse
3222 PHOENIXVILLE PIKE, MALVERN, PA
Vergleichen Sie STIM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
0.9631 | 28.44M | 69.23M | -33.10M | -39.26M | -1.13 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-13 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2018-07-24 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Neuronetics Inc Aktie (STIM) Neueste Nachrichten
Transcranial Magnetic Stimulator Market Overall Study Report - openPR
GSA Capital Partners LLP Purchases 30,837 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Transcranial Magnetic Stimulator Market Future Business - openPR
FDA Clears NeuroStar's TMS Therapy for Adolescents with Major Depressive Disorder - MSN
Neuronetics to Showcase Neurohealth Innovations at Piper Sandler Healthcare Conference! - MSN
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics - TipRanks
Neuronetics Announces Q3 2024 Financial Results and Greenbrook TMS Acquisition Approval - MSN
Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Neuronetics to Present at Piper Sandler Healthcare Conference in December 2024 | STIM Stock News - StockTitan
Neuronetics Grants Inducement Awards to New Employees - MSN
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MSN
Neuronetics, Inc. (NASDAQ:STIM) Analysts Just Slashed Next Year's Revenue Estimates By 12% - Simply Wall St
Neuronetics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Need To Know: The Consensus Just Cut Its Neuronetics, Inc. (NASDAQ:STIM) Estimates For 2025 - Yahoo Finance
William Blair Decreases Earnings Estimates for Neuronetics - Defense World
Greenbrook TMS Acquisition by Neuronetics Approved - TipRanks
Neuronetics, Inc. (NASDAQ:STIM) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Neuronetics regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia
CANNELL CAPITAL LLC Adjusts Stake in Neuronetics Inc - GuruFocus.com
Neuronetics Inc. (STIM) Quarterly 10-Q Report - Quartzy
Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Earnings call: Neuronetics reports revenue growth amidst strategic shifts By Investing.com - Investing.com Nigeria
Neuronetics regains Nasdaq compliance with bid price - Investing.com
Earnings call: Neuronetics reports revenue growth amidst strategic shifts - Investing.com
Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript - Insider Monkey
Neuronetics announces inducement grant - Medical Buyer
Neuronetics Regains Nasdaq Compliance with Bid Price - TipRanks
Neuronetics stock hits 52-week low at $0.66 amid market challenges - Investing.com Australia
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and Strategic Shifts - GuruFocus.com
Neuronetics, Inc. Holds Special Meeting of Stockholders and Receives Approval for Various ProposalsNeuronetics, Inc. (NASDAQ: STIM) recently conducted a Special Meeting of Stockholders on November 8, 2024, whereby several proposals were put forth fo - Defense World
Neuronetics (NASDAQ: STIM) Announces Key Financial Updates and FDA Clearance for Adolescent Treatment - Defense World
Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... - Yahoo Finance
Neuronetics Reports Growth and Strategic Acquisition - TipRanks
CORRECTION-Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - The Manila Times
Neuronetics Q3 Revenue Grows 4%, Margins Surge Despite Widening Losses | STIM Stock | STIM Stock News - StockTitan
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Awards 13,500 RSUs to New Employees in Key Talent Acquisition Move | STIM Stock News - StockTitan
500: Something went wrong - Investing.com India
U.S. Stock market: BTC Digital(+314.68%), BTCS Inc.(+35.64%), Neuronetics(−41.36%) among most volatile stocks during mid day trading - Business Upturn
Neuronetics Inc (STIM) Q3 2024 Earnings: EPS of $(0.44) Misses E - GuruFocus.com
U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn
Neuronetics: Q3 Earnings Snapshot - San Antonio Express-News
Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results - The Manila Times
Neuronetics Q3 Revenue Grows 4% to $18.5M, Margins Surge Despite Wider Losses | STIM Stock News - StockTitan
Greenbrook TMS Shareholders Approve Neuronetics Acquisition - TipRanks
Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Neuronetics (STIM) Set to Announce Quarterly Earnings on Tuesday - Defense World
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St
Finanzdaten der Neuronetics Inc-Aktie (STIM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Neuronetics Inc-Aktie (STIM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | EVP, GC, CCO and CS |
Oct 08 '24 |
Sale |
0.82 |
1,541 |
1,264 |
402,792 |
1.43%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):